| 1 | Long-term HIV care outcomes under universal HIV treatment guidelines: A retrospective cohort study in 25 countries | 8.5 | 8 | Citations (PDF) |
| 2 | HIV self-testing for men who have sex with men: an implementation trial in Indonesia | 1.5 | 6 | Citations (PDF) |
| 3 | Time trends in cancer incidence in Australian people living with HIV between 1982 and 2012 | 2.9 | 19 | Citations (PDF) |
| 4 | Weight changes, metabolic syndrome and all‐cause mortality among Asian adults living with HIV | 2.9 | 16 | Citations (PDF) |
| 5 | The impact of removing financial incentives and/or audit and feedback on chlamydia testing in general practice: A cluster randomised controlled trial (ACCEPt-able) | 8.5 | 10 | Citations (PDF) |
| 6 | Impact of Testing Strategies to Combat a Major Syphilis Outbreak Among Australian Aboriginal and Torres Strait Islander Peoples: A Mathematical Modeling Study | 0.8 | 6 | Citations (PDF) |
| 7 | Incidence of hypertension in people with HIV who are treated with integrase inhibitors versus other antiretroviral regimens in the RESPOND cohort consortium | 2.9 | 51 | Citations (PDF) |
| 8 | The response to COVID-19 among drug retail outlets in Indonesia: A cross-sectional survey of knowledge, attitudes, and practices | 3.6 | 3 | Citations (PDF) |
| 9 | The seasonality of infections in tropical Far North Queensland, Australia: A 21-year retrospective evaluation of the seasonal patterns of six endemic pathogens | 2.2 | 21 | Citations (PDF) |
| 10 | Risk of variant <scp>Creutzfeldt–Jakob</scp> disease transmission by blood transfusion in Australia | 1.1 | 14 | Citations (PDF) |
| 11 | Risk of hepatitis C reinfection following successful therapy among people living with HIV: a global systematic review, meta-analysis, and meta-regression | 8.1 | 45 | Citations (PDF) |
| 12 | The Impact of Immunosuppression on Chronic Kidney Disease in People Living With Human Immunodeficiency Virus: The D:A:D Study | 3.8 | 7 | Citations (PDF) |
| 13 | High hepatitis C treatment uptake among people with recent drug dependence in New South Wales, Australia | 3.6 | 34 | Citations (PDF) |
| 14 | The comparative ability of commonly used disease severity scores to predict death or a requirement for ICU care in patients hospitalised with possible sepsis in Yangon, Myanmar | 2.2 | 9 | Citations (PDF) |
| 15 | Cost‐effectiveness of statins for primary prevention of atherosclerotic cardiovascular disease among people living with HIV in the United States | 3.6 | 9 | Citations (PDF) |
| 16 | Effect of Changes in Body Mass Index on the Risk of Cardiovascular Disease and Diabetes Mellitus in HIV-Positive Individuals: Results From the D:A:D Study | 1.8 | 23 | Citations (PDF) |
| 17 | Factors Associated With and Characteristic of HIV/Tuberculosis Co-Infection: A Retrospective Analysis of SECOND-LINE Clinical Trial Participants | 1.8 | 4 | Citations (PDF) |
| 18 | Antiseptic mouthwash for gonorrhoea prevention (OMEGA): a randomised, double-blind, parallel-group, multicentre trial | 15.7 | 35 | Citations (PDF) |
| 19 | Opportunities to Enhance Linkage to Hepatitis C Care Among Hospitalized People With Recent Drug Dependence in New South Wales, Australia: A Population-based Linkage Study | 5.4 | 12 | Citations (PDF) |
| 20 | Azithromycin or Doxycycline for Asymptomatic Rectal <i>Chlamydia trachomatis</i> | 43.7 | 65 | Citations (PDF) |
| 21 | Estimation of Potential HIV Transmission Risk in Recent Anal Intercourse Events among Men Who Have Sex with Men and Transgender Women in Bali, Indonesia | 2.3 | 5 | Citations (PDF) |
| 22 | Prevalence and determinants of inappropriate antibiotic dispensing at private drug retail outlets in urban and rural areas of Indonesia: a mixed methods study | 4.7 | 24 | Citations (PDF) |
| 23 | The longer-term effects of access to HIV self-tests on HIV testing frequency in high-risk gay and bisexual men: follow-up data from a randomised controlled trial | 3.6 | 10 | Citations (PDF) |
| 24 | Trends in Follow-Up Visits Among People Living With HIV: Results From the TREAT Asia and Australian HIV Observational Databases | 1.8 | 0 | Citations (PDF) |
| 25 | Atherosclerotic cardiovascular disease thresholds for statin initiation among people living with HIV in Thailand: A cost-effectiveness analysis | 2.4 | 1 | Citations (PDF) |
| 26 | Clinical Outcomes of 2-Drug Regimens vs 3-Drug Regimens in Antiretroviral Treatment–Experienced People Living With Human Immunodeficiency Virus | 5.4 | 19 | Citations (PDF) |
| 27 | Modelling response strategies for controlling gonorrhoea outbreaks in men who have sex with men in Australia | 3.1 | 7 | Citations (PDF) |
| 28 | Global estimates of viral suppression in children and adolescents and adults on antiretroviral therapy adjusted for missing viral load measurements: a multiregional, retrospective cohort study in 31 countries | 8.1 | 87 | Citations (PDF) |
| 29 | Can Australia Reach the World Health Organization Hepatitis C Elimination Goal by 2025 Among Human Immunodeficiency Virus–positive Gay and Bisexual Men? | 5.4 | 12 | Citations (PDF) |
| 30 | Hepatitis C reinfection after successful antiviral treatment among people who inject drugs: A meta-analysis | 3.6 | 154 | Citations (PDF) |
| 31 | Prevalence and Association of Perianal and Intra-Anal Warts with Composite High-Grade Squamous Intraepithelial Lesions Among Gay and Bisexual Men: Baseline Data from the Study of the Prevention of Anal Cancer | 2.8 | 11 | Citations (PDF) |
| 32 | Intra-cerebral haemorrhage but not neurodegenerative disease appears over-represented in deaths of Australian cadaveric pituitary hormone recipients | 1.6 | 2 | Citations (PDF) |
| 33 | Determining standardized causes of death of infants, children, and adolescents living with HIV in AsiaAids, 2020, 34, 1527-1537 | 2.5 | 17 | Citations (PDF) |
| 34 | Cardiovascular disease among people living with HIV in Brazil | 2.0 | 12 | Citations (PDF) |
| 35 | PS-SiZer map to investigate significant features of body-weight profile changes in HIV infected patients in the IeDEA Collaboration | 2.4 | 0 | Citations (PDF) |
| 36 | Statins for atherosclerotic cardiovascular disease prevention in people living with HIV in Thailand: a cost‐effectiveness analysis | 3.6 | 8 | Citations (PDF) |
| 37 | Uptake and Discontinuation of Integrase Inhibitors (INSTIs) in a Large Cohort Setting | 1.8 | 31 | Citations (PDF) |
| 38 | Comorbidity Medications Are Dispensed to More People Receiving Antiretroviral Therapy for HIV Compared with the General Population in Australia | 1.5 | 5 | Citations (PDF) |
| 39 | Treatment Modification after Second-Line Failure among People Living with HIV in Asia-Pacific | 2.1 | 2 | Citations (PDF) |
| 40 | An Expanded HIV Care Cascade: ART Uptake, Viral Load Suppression and Comorbidity Monitoring among Adults Living with HIV in Asia | 2.1 | 4 | Citations (PDF) |
| 41 | Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium | 2.4 | 9 | Citations (PDF) |
| 42 | Cessation of Cigarette Smoking and the Impact on Cancer Incidence in Human Immunodeficiency Virus–infected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study | 5.4 | 21 | Citations (PDF) |
| 43 | Use and Outcomes of Antiretroviral Monotherapy and Treatment Interruption in Adolescents With Perinatal HIV Infection in Asia | 2.8 | 0 | Citations (PDF) |
| 44 | Use of Contemporary Protease Inhibitors and Risk of Incident Chronic Kidney Disease in Persons With Human Immunodeficiency Virus: the Data Collection on Adverse Events of Anti-HIV Drugs (D:A:D) Study | 3.8 | 15 | Citations (PDF) |
| 45 | Strategies to improve control of sexually transmissible infections in remote Australian Aboriginal communities: a stepped-wedge, cluster-randomised trial | 14.0 | 18 | Citations (PDF) |
| 46 | Incomplete recording of Indigenous identification status under-estimates the prevalence of Indigenous population attending Australian general practices: a cross sectional study | 2.6 | 6 | Citations (PDF) |
| 47 | Predictors of Ischemic and Hemorrhagic Strokes Among People Living With HIV: The D:A:D International Prospective Multicohort Study | 8.5 | 16 | Citations (PDF) |
| 48 | Effect Estimates in Randomized Trials and Observational Studies: Comparing Apples With Apples | 3.4 | 100 | Citations (PDF) |
| 49 | Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia | 3.6 | 92 | Citations (PDF) |
| 50 | Combined oral contraceptive pill-exposure alone does not reduce the risk of bacterial vaginosis recurrence in a pilot randomised controlled trial | 3.5 | 26 | Citations (PDF) |
| 51 | Cardiovascular Disease Incidence Projections in the TREAT Asia HIV Observational Database (TAHOD) | 2.1 | 5 | Citations (PDF) |
| 52 | Estimating the number of people who inject drugs and syringe coverage in Australia, 2005–2016 | 3.0 | 26 | Citations (PDF) |
| 53 | Attrition and treatment outcomes among adolescents and youths living with HIV in the Thai National AIDS Program | 0.4 | 14 | Citations (PDF) |
| 54 | Incidence and time trends of anal cancer among people living with HIV in AustraliaAids, 2019, 33, 1361-1368 | 2.5 | 30 | Citations (PDF) |
| 55 | Serious clinical events in HIV-positive persons with chronic kidney diseaseAids, 2019, 33, 2173-2188 | 2.5 | 13 | Citations (PDF) |
| 56 | Predictive Performance of Cardiovascular Disease Risk Prediction Algorithms in People Living With HIV | 1.8 | 32 | Citations (PDF) |
| 57 | ART in HIV-Positive Persons With Low Pretreatment Viremia: Results From the START Trial | 1.8 | 12 | Citations (PDF) |
| 58 | Sexual practices have a significant impact on the vaginal microbiota of women who have sex with women | 3.5 | 36 | Citations (PDF) |
| 59 | HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme | 3.3 | 11 | Citations (PDF) |
| 60 | Gender differences in the use of cardiovascular interventions in <scp>HIV</scp>‐positive persons; the D:A:D Study | 3.6 | 13 | Citations (PDF) |
| 61 | Global Trends in CD4 Cell Count at the Start of Antiretroviral Therapy: Collaborative Study of Treatment Programs | 5.4 | 117 | Citations (PDF) |
| 62 | Which HIV-infected adults with high CD4 T-cell counts benefit most from immediate initiation of antiretroviral therapy? A post-hoc subgroup analysis of the START trial | 8.1 | 34 | Citations (PDF) |
| 63 | Impact of replacing cytology with human papillomavirus testing for cervical cancer screening on the prevalence of <i>Trichomonas vaginalis</i>: a modelling study | 2.7 | 6 | Citations (PDF) |
| 64 | Differences in Virological and Immunological Risk Factors for Non-Hodgkin and Hodgkin Lymphoma | 4.7 | 19 | Citations (PDF) |
| 65 | Cardiovascular disease and use of contemporary protease inhibitors: the D:A:D international prospective multicohort study | 8.1 | 201 | Citations (PDF) |
| 66 | Rates of pelvic inflammatory disease and ectopic pregnancy in Australia, 2009–2014: ecological analysis of hospital data | 2.7 | 17 | Citations (PDF) |
| 67 | Concordance of gonorrhoea of the rectum, pharynx and urethra in same-sex male partnerships attending a sexual health service in Melbourne, Australia | 2.8 | 18 | Citations (PDF) |
| 68 | Loss to follow-up and Associated Factors of Patients in the National AIDS Program in Thailand | 2.1 | 9 | Citations (PDF) |
| 69 | Abacavir use and risk of recurrent myocardial infarction | 2.5 | 18 | Citations (PDF) |
| 70 | Trends in hepatocellular carcinoma incidence and survival among people with hepatitis C: An international study | 2.1 | 22 | Citations (PDF) |
| 71 | The contribution of alcohol use disorder to decompensated cirrhosis among people with hepatitis C: An international study | 3.6 | 72 | Citations (PDF) |
| 72 | People Born in Non–Main English Speaking Countries Are Less Likely to Start HIV Treatment Early in Australia: A National Cohort Analysis, 2014–15 | 1.8 | 10 | Citations (PDF) |
| 73 | Aging of the HIV Population in Australia: A Modeling Study | 1.8 | 8 | Citations (PDF) |
| 74 | Mortality and losses to follow‐up among adolescents living with <scp>HIV</scp> in the Ie<scp>DEA</scp> global cohort collaboration | 3.6 | 71 | Citations (PDF) |
| 75 | Characteristics, mortality and outcomes at transition for adolescents with perinatal HIV infection in AsiaAids, 2018, 32, 1689-1697 | 2.5 | 10 | Citations (PDF) |
| 76 | Direct-acting antiviral treatment for hepatitis C among people who use or inject drugs: a systematic review and meta-analysis | 23.6 | 202 | Citations (PDF) |
| 77 | Vorapaxar for HIV-associated inflammation and coagulopathy (ADVICE): a randomised, double-blind, placebo-controlled trial | 8.1 | 21 | Citations (PDF) |
| 78 | Population effectiveness of opportunistic chlamydia testing in primary care in Australia: a cluster-randomised controlled trial | 52.8 | 83 | Citations (PDF) |
| 79 | Body Mass Index and the Risk of Serious Non-AIDS Events and All-Cause Mortality in Treated HIV-Positive Individuals: D:A:D Cohort Analysis | 1.8 | 49 | Citations (PDF) |
| 80 | Associations between serum albumin and serious non-AIDS events among people living with HIVAids, 2018, 32, 1837-1848 | 2.5 | 6 | Citations (PDF) |
| 81 | Sex‐based differences in antiretroviral therapy initiation, switching and treatment interruptions: global overview from the International Epidemiologic Databases to Evaluate AIDS (IeDEA) | 3.6 | 22 | Citations (PDF) |
| 82 | Early suboptimal ART adherence was associated with missed clinical visits in HIV-infected patients in Asia | 1.5 | 11 | Citations (PDF) |
| 83 | Mortality trends among people with hepatitis B and C: a population-based linkage study, 1993-2012 | 2.8 | 26 | Citations (PDF) |
| 84 | The cascade of HIV care among key populations in Indonesia: a prospective cohort study | 8.1 | 88 | Citations (PDF) |
| 85 | Temporal Trends in Co-trimoxazole Use Among Children on Antiretroviral Therapy and the Impact of Co-trimoxazole on Mortality Rates in Children Without Severe Immunodeficiency | 1.5 | 5 | Citations (PDF) |
| 86 | A pseudo-random patient sampling method evaluated | 3.7 | 12 | Citations (PDF) |
| 87 | Effect of availability of HIV self-testing on HIV testing frequency in gay and bisexual men at high risk of infection (FORTH): a waiting-list randomised controlled trial | 8.1 | 143 | Citations (PDF) |
| 88 | Growing challenges for HIV programmes in Asia: clinic population trends, 2003–2013 | 1.5 | 2 | Citations (PDF) |
| 89 | CD4:CD8 Ratio Comparison between Cohorts of HIV-Positive Asians and Caucasians upon Commencement of Antiretroviral Therapy | 2.1 | 17 | Citations (PDF) |
| 90 | Life Expectancy after Initiation of Combination Antiretroviral Therapy in Thailand | 2.1 | 31 | Citations (PDF) |
| 91 | Predictors of estimated glomerular filtration rate progression, stabilization or improvement after chronic renal impairment in HIV-positive individualsAids, 2017, 31, 1261-1270 | 2.5 | 17 | Citations (PDF) |
| 92 | Trends in CD4 cell count response to first-line antiretroviral treatment in HIV-positive patients from Asia, 2003–2013: TREAT Asia HIV Observational Database Low Intensity Transfer | 1.3 | 9 | Citations (PDF) |
| 93 | Identifying factors that lead to the persistence of imported<i>gonorrhoeae</i>strains: a modelling study | 2.7 | 9 | Citations (PDF) |
| 94 | HIV and Aging: Demographic Change in the Asia-Pacific Region | 1.8 | 24 | Citations (PDF) |
| 95 | High HIV Prevalence and Risk Among Male Clients of Female Sex Workers in Hanoi and Ho Chi Minh City, Vietnam | 2.0 | 16 | Citations (PDF) |
| 96 | Attrition and Mortality of Children Receiving Antiretroviral Treatment through the Universal Coverage Health Program in Thailand | 2.0 | 13 | Citations (PDF) |
| 97 | First-Line Antiretroviral Treatment Outcomes and Durability in HIV-Infected Children Treated Through the Universal Coverage Health Program in Thailand | 1.8 | 3 | Citations (PDF) |
| 98 | Circulating miR-122 and miR-200a as biomarkers for fatal liver disease in ART-treated, HIV-1-infected individuals | 3.5 | 39 | Citations (PDF) |
| 99 | All-cause mortality in HIV-positive adults starting combination antiretroviral therapy | 2.5 | 28 | Citations (PDF) |
| 100 | Loss to Follow-up Trends in HIV-Positive Patients Receiving Antiretroviral Treatment in Asia From 2003 to 2013 | 1.8 | 25 | Citations (PDF) |
| 101 | Targeted human papillomavirus vaccination for young men who have sex with men in Australia yields significant population benefits and is cost-effective | 3.2 | 49 | Citations (PDF) |
| 102 | Hepatocellular carcinoma risk following direct-acting antiviral HCV therapy: A systematic review, meta-analyses, and meta-regression | 3.6 | 447 | Citations (PDF) |
| 103 | HIV Viral Load Suppression in Adults and Children Receiving Antiretroviral Therapy—Results From the IeDEA Collaboration | 1.8 | 65 | Citations (PDF) |
| 104 | The treatment outcomes of antiretroviral substitutions in routine clinical settings in Asia; data from the <scp>TREAT</scp> Asia <scp>HIV</scp> Observational Database (<scp>TAHOD</scp>) | 3.6 | 3 | Citations (PDF) |
| 105 | Factors associated with pre-treatment HIV RNA: application for the use of abacavir and rilpivirine as the first-line regimen for HIV-infected patients in resource-limited settings | 2.3 | 0 | Citations (PDF) |
| 106 | Survival following hospitalization with hepatocellular carcinoma among people notified with hepatitis B or C virus in Australia (2000‐2014) | 4.7 | 9 | Citations (PDF) |
| 107 | Hepatitis C testing and re-testing among people attending sexual health services in Australia, and hepatitis C incidence among people with human immunodeficiency virus: analysis of national sentinel surveillance data | 2.8 | 5 | Citations (PDF) |
| 108 | The influence of sexual activity on the vaginal microbiota and Gardnerella vaginalis clade diversity in young women | 2.4 | 110 | Citations (PDF) |
| 109 | Prevalence of self-reported comorbidities in HIV positive and HIV negative men who have sex with men over 55 years—The Australian Positive & Peers Longevity Evaluation Study (APPLES) | 2.4 | 44 | Citations (PDF) |
| 110 | Cardiovascular disease (CVD) and chronic kidney disease (CKD) event rates in HIV-positive persons at high predicted CVD and CKD risk: A prospective analysis of the D:A:D observational study | 8.5 | 24 | Citations (PDF) |
| 111 | Comprehensiveness of HIV care provided at global HIV treatment sites in the IeDEA consortium: 2009 and 2014 | 3.6 | 17 | Citations (PDF) |
| 112 | Cardiovascular Disease and Cardiovascular Disease Risk in HIV-Positive Populations in the Asian Region | 0.6 | 13 | Citations (PDF) |
| 113 | Tenofovir-Based Antiretroviral Therapy in HBV–HIV Coinfection: Results from the TREAT Asia HIV Observational Database | 2.1 | 9 | Citations (PDF) |
| 114 | Smoking, alcohol and illicit drug use effects on survival in HIV-positive persons | 3.3 | 54 | Citations (PDF) |
| 115 | Use of antiretroviral therapy and risk of end-stage liver disease and hepatocellular carcinoma in HIV-positive personsAids, 2016, 30, 1731-1743 | 2.5 | 56 | Citations (PDF) |
| 116 | Time to decompensated cirrhosis and hepatocellular carcinoma after an HBV or HCV notification: A population-based study | 3.6 | 32 | Citations (PDF) |
| 117 | Is nelfinavir exposure associated with cancer incidence in HIV-positive individuals?Aids, 2016, 30, 1629-1637 | 2.5 | 9 | Citations (PDF) |
| 118 | Improvements over time in short-term mortality following myocardial infarction in HIV-positive individualsAids, 2016, 30, 1583-1596 | 2.5 | 10 | Citations (PDF) |
| 119 | The per-protocol effect of immediate versus deferred antiretroviral therapy initiationAids, 2016, 30, 2659-2663 | 2.5 | 26 | Citations (PDF) |
| 120 | Antiretroviral Drugs and Risk of Chronic Alanine Aminotransferase Elevation in Human Immunodeficiency Virus (HIV)-Monoinfected Persons: The Data Collection on Adverse Events of Anti-HIV Drugs Study | 0.8 | 24 | Citations (PDF) |
| 121 | Renal Impairment and Cardiovascular Disease in HIV-Positive Individuals: The D:A:D Study | 3.8 | 44 | Citations (PDF) |
| 122 | Trends in hepatocellular carcinoma among people with HBV or HCV notification in Australia (2000–2014) | 3.6 | 41 | Citations (PDF) |
| 123 | Improved Survival in HIV Treatment Programmes in Asia | 2.1 | 20 | Citations (PDF) |
| 124 | High hepatitis C virus (HCV) prevalence among men who have sex with men (MSM) in Vietnam and associated risk factors: 2010 Vietnam Integrated Behavioural and Biologic Cross-Sectional Survey | 2.7 | 15 | Citations (PDF) |
| 125 | Hospitalization for Anxiety and Mood Disorders in HIV-Infected and -Uninfected Gay and Bisexual Men | 1.8 | 10 | Citations (PDF) |
| 126 | Longitudinal Analysis of the Associations between Antiretroviral Therapy, Viraemia and Immunosuppression with Lipid Levels: The D:A:D Study | 2.1 | 25 | Citations (PDF) |
| 127 | Is there continued evidence for an association between abacavir usage and myocardial infarction risk in individuals with HIV? A cohort collaboration | 7.5 | 111 | Citations (PDF) |
| 128 | Effects of unplanned treatment interruptions on <scp>HIV</scp> treatment failure – results from <scp>TAHOD</scp> | 2.0 | 20 | Citations (PDF) |
| 129 | The occurrence of Simpson's paradox if site-level effect was ignored in the TREAT Asia HIV Observational Database | 3.7 | 5 | Citations (PDF) |
| 130 | Poor record linkage sensitivity biased outcomes in a linked cohort analysis | 3.7 | 11 | Citations (PDF) |
| 131 | Patterns of Drug Use and Drug-related Hospital Admissions in HIV-Positive and -Negative Gay and Bisexual Men | 2.0 | 9 | Citations (PDF) |
| 132 | An updated prediction model of the global risk of cardiovascular disease in HIV-positive persons: The Data-collection on Adverse Effects of Anti-HIV Drugs (D:A:D) study | 2.1 | 213 | Citations (PDF) |
| 133 | Hepatitis B and C Co-Infection in HIV Patients from the TREAT Asia HIV Observational Database: Analysis of Risk Factors and Survival | 2.4 | 47 | Citations (PDF) |
| 134 | Recent Trends in Early Stage Response to Combination Antiretroviral Therapy in Australia | 2.1 | 6 | Citations (PDF) |
| 135 | Loss to follow-up in the Australian HIV Observational Database | 2.1 | 19 | Citations (PDF) |
| 136 | Implementation and Operational Research | 1.8 | 16 | Citations (PDF) |
| 137 | Implementation and Operational Research | 1.8 | 9 | Citations (PDF) |
| 138 | Temporal trends of time to antiretroviral treatment initiation, interruption and modification: examination of patients diagnosed with advanced HIV in Australia | 3.6 | 11 | Citations (PDF) |
| 139 | Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study | 2.4 | 45 | Citations (PDF) |
| 140 | Subsidized optimal ART for HIV-positive temporary residents of Australia improves virological outcomes: results from the Australian HIV Observational Database Temporary Residents Access Study | 3.6 | 10 | Citations (PDF) |
| 141 | Innovations in health and demographic surveillance systems to establish the causal impacts of HIV policies | 3.3 | 24 | Citations (PDF) |
| 142 | Incident Bacterial Vaginosis (BV) in Women Who Have Sex With Women Is Associated With Behaviors That Suggest Sexual Transmission of BV | 5.4 | 81 | Citations (PDF) |
| 143 | Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study | 8.5 | 134 | Citations (PDF) |
| 144 | Efficacy of Second-Line Antiretroviral Therapy Among People Living With HIV/AIDS in Asia | 1.8 | 28 | Citations (PDF) |
| 145 | Human papillomavirus in young women with Chlamydia trachomatis infection 7 years after the Australian human papillomavirus vaccination programme: a cross-sectional study | 15.7 | 60 | Citations (PDF) |
| 146 | Risk group characteristics and viral transmission clusters in South‐East Asian patients infected with human immunodeficiency virus‐1 (HIV‐1) circulating recombinant form (CRF) 01_AE and subtype B | 2.8 | 3 | Citations (PDF) |
| 147 | Antiretroviral treatment use, co-morbidities and clinical outcomes among Aboriginal participants in the Australian HIV Observational Database (AHOD) | 2.8 | 6 | Citations (PDF) |
| 148 | Site-specific human papillomavirus infection in adolescent men who have sex with men (HYPER): an observational cohort study | 15.7 | 44 | Citations (PDF) |
| 149 | Trends in mortality after diagnosis of hepatitis C virus infection: An international comparison and implications for monitoring the population impact of treatment | 3.6 | 36 | Citations (PDF) |
| 150 | High HIV Prevalence and Associated Risk Factors Among Female Sexual Partners of Male Injection Drug Users (MWID) in Ho Chi Minh City, Vietnam | 2.0 | 7 | Citations (PDF) |
| 151 | Findings from Integrated Behavioral and Biologic Survey among Males Who Inject Drugs (MWID) — Vietnam, 2009–2010: Evidence of the Need for an Integrated Response to HIV, Hepatitis B Virus, and Hepatitis C Virus | 2.4 | 18 | Citations (PDF) |
| 152 | Factors Associated with Bacterial Vaginosis among Women Who Have Sex with Women: A Systematic Review | 2.4 | 51 | Citations (PDF) |
| 153 | Quilt Plots: A Simple Tool for the Visualisation of Large Epidemiological Data | 2.4 | 7 | Citations (PDF) |
| 154 | The Significance of HIV ‘Blips’ in Resource-Limited Settings: Is It the Same? Analysis of the Treat Asia HIV Observational Database (TAHOD) and the Australian HIV Observational Database (AHOD) | 2.4 | 10 | Citations (PDF) |
| 155 | Moving Away from Ritonavir, Abacavir, Tenofovir, and Efavirenz (RATE) - Agents That Concern Prescribers and Patients: A Feasibility Study and Call for a Trial | 2.4 | 5 | Citations (PDF) |
| 156 | Trends in First-Line Antiretroviral Therapy in Asia: Results from the TREAT Asia HIV Observational Database | 2.4 | 20 | Citations (PDF) |
| 157 | Factors Associated with Participation and Attrition in a Longitudinal Study of Bacterial Vaginosis in Australian Women Who Have Sex with Women | 2.4 | 14 | Citations (PDF) |
| 158 | HIV multi‐drug resistance at first‐line antiretroviral failure and subsequent virological response in Asia | 3.6 | 14 | Citations (PDF) |
| 159 | Chlamydia prevalence in young attenders of rural and regional primary care services in Australia: a cross‐sectional survey | 1.8 | 33 | Citations (PDF) |
| 160 | Factors associated with suboptimal adherence to antiretroviral therapy in Asia | 3.6 | 35 | Citations (PDF) |
| 161 | Improving chlamydia knowledge should lead to increased chlamydia testing among Australian general practitioners: a cross-sectional study of chlamydia testing uptake in general practice | 2.8 | 12 | Citations (PDF) |
| 162 | Relationship between CD4 cell count and serious long-term complications among HIV-positive individuals | 3.3 | 14 | Citations (PDF) |
| 163 | Comparison of central and local HIV-1 RNA quantification from two international clinical trialsAids, 2014, 28, 2480-2483 | 2.5 | 0 | Citations (PDF) |
| 164 | Relationship Between Hyperglycemia and the Risk of Tuberculosis in Asian HIV-Positive Individuals in the Antiretroviral Therapy Era | 1.8 | 4 | Citations (PDF) |
| 165 | Eradicating syphilis, hepatitis C and HIV in MSM through frequent testing strategies | 3.5 | 26 | Citations (PDF) |
| 166 | Global burden of transmitted HIV drug resistance and HIV-exposure categoriesAids, 2014, 28, 2751-2762 | 2.5 | 90 | Citations (PDF) |
| 167 | A Clinical Prediction Tool for Targeted Pre-antiretroviral Therapy Creatinine Testing Applied to the TREAT Asia HIV Observational Database Cohort | 1.8 | 0 | Citations (PDF) |
| 168 | Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI) | 1.9 | 73 | Citations (PDF) |
| 169 | The Influence of Behaviors and Relationships on the Vaginal Microbiota of Women and Their Female Partners: The WOW Health Study | 3.8 | 75 | Citations (PDF) |
| 170 | Trends in underlying causes of death in people with HIV from 1999 to 2011 (D:A:D): a multicohort collaboration | 52.8 | 851 | Citations (PDF) |
| 171 | Improving the clinical prediction of detrusor overactivity by utilizing additional symptoms and signs to overactive bladder symptoms alone | 1.6 | 9 | Citations (PDF) |
| 172 | Predictors of advanced chronic kidney disease and end-stage renal disease in HIV-positive persons | 2.5 | 62 | Citations (PDF) |
| 173 | Cancer Incidence in a Nationwide HIV/AIDS Patient Cohort in Taiwan in 1998–2009 | 1.8 | 37 | Citations (PDF) |
| 174 | Determinants of Suicide and Accidental or Violent Death in the Australian HIV Observational Database | 2.4 | 30 | Citations (PDF) |
| 175 | Testing Commercial Sex Workers for Sexually Transmitted Infections in Victoria, Australia: An Evaluation of the Impact of Reducing the Frequency of Testing | 2.4 | 49 | Citations (PDF) |
| 176 | A New Method for Assessing How Sensitivity and Specificity of Linkage Studies Affects Estimation | 2.4 | 33 | Citations (PDF) |
| 177 | Changes in Metabolic, Inflammatory and Coagulation Biomarkers after HIV Seroconversion – the Health in Men (Him) Biomarker Substudy | 2.1 | 4 | Citations (PDF) |
| 178 | Population movement can sustain STI prevalence in remote Australian indigenous communities | 2.8 | 18 | Citations (PDF) |
| 179 | The association of HPV-16 seropositivity and natural immunity to reinfection: insights from compartmental models | 2.8 | 1 | Citations (PDF) |
| 180 | Herd immunity effect of the HPV vaccination program in Australia under different assumptions regarding natural immunity against re-infection | 3.2 | 8 | Citations (PDF) |
| 181 | Contribution of Genetic Background, Traditional Risk Factors, and HIV-Related Factors to Coronary Artery Disease Events in HIV-Positive Persons | 5.4 | 65 | Citations (PDF) |
| 182 | The chlamydia knowledge, awareness and testing practices of Australian general practitioners and practice nurses: survey findings from the Australian Chlamydia Control Effectiveness Pilot (ACCEPt) | 3.1 | 14 | Citations (PDF) |
| 183 | Associations between immune depression and cardiovascular events in HIV infectionAids, 2013, 27, 2735-2748 | 2.5 | 56 | Citations (PDF) |
| 184 | Intensity of human prion disease surveillance predicts observed disease incidence | 7.3 | 70 | Citations (PDF) |
| 185 | Near Elimination of Genital Warts in Australia Predicted With Extension of Human Papillomavirus Vaccination to Males | 1.3 | 44 | Citations (PDF) |
| 186 | Recurrence of Bacterial Vaginosis Is Significantly Associated With Posttreatment Sexual Activities and Hormonal Contraceptive Use | 5.4 | 138 | Citations (PDF) |
| 187 | Association Between ALT Level and the Rate of Cardio/Cerebrovascular Events in HIV-Positive Individuals | 1.8 | 14 | Citations (PDF) |
| 188 | Evaluating Immunologic Response and Clinical Deterioration in Treatment-Naive Patients Initiating First-Line Therapies Infected With HIV–1 CRF01_AE and Subtype B | 1.8 | 16 | Citations (PDF) |
| 189 | Non-AIDS defining cancers in the D:A:D Study - time trends and predictors of survival: a cohort study | 2.8 | 71 | Citations (PDF) |
| 190 | Rates and Factors Associated with Major Modifications to First-Line Combination Antiretroviral Therapy: Results from the Asia-Pacific Region | 2.4 | 14 | Citations (PDF) |
| 191 | Hormonal Contraception Is Associated with a Reduced Risk of Bacterial Vaginosis: A Systematic Review and Meta-Analysis | 2.4 | 145 | Citations (PDF) |
| 192 | Estimated mortality of adult HIV-infected patients starting treatment with combination antiretroviral therapy | 2.7 | 52 | Citations (PDF) |
| 193 | Loss to Followup in HIV-Infected Patients from Asia-Pacific Region: Results from TAHOD | 1.1 | 34 | Citations (PDF) |
| 194 | Serum Macrophage Inhibitory Cytokine-1 (MIC-1/GDF15): A Potential Screening Tool for the Prevention of Colon Cancer? | 1.2 | 61 | Citations (PDF) |
| 195 | Granulocyte colony stimulating factor in chronic angina to stimulate neovascularisation: a placebo controlled crossover trial | 4.3 | 17 | Citations (PDF) |
| 196 | Macrophage inhibitory cytokine-1 (MIC-1/GDF15) and mortality in end-stage renal disease | 0.8 | 103 | Citations (PDF) |
| 197 | Estimating the cost-effectiveness of needle-syringe programs in AustraliaAids, 2012, 26, 2201-2210 | 2.5 | 84 | Citations (PDF) |
| 198 | Reclassification of risk of death with the knowledge of D-dimer in a cohort of treated HIV-infected individualsAids, 2012, 26, 1707-1717 | 2.5 | 8 | Citations (PDF) |
| 199 | Early versus deferred antiretroviral therapy for children older than 1 year infected with HIV (PREDICT): a multicentre, randomised, open-label trial | 15.7 | 80 | Citations (PDF) |
| 200 | Long-Term Survival in HIV Positive Patients with up to 15 Years of Antiretroviral Therapy | 2.4 | 68 | Citations (PDF) |
| 201 | Hepatitis C treatment outcomes in Australian clinics | 1.8 | 27 | Citations (PDF) |
| 202 | Predicting the short‐term risk of diabetes in HIV‐positive patients: the Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) study | 3.6 | 63 | Citations (PDF) |
| 203 | Failure to prescribe pneumocystis prophylaxis is associated with increased mortality, even in the cART era: results from the Treat Asia HIV observational database | 3.6 | 94 | Citations (PDF) |
| 204 | Short‐term risk of anaemia following initiation of combination antiretroviral treatment in HIV‐infected patients in countries in sub‐Saharan Africa, Asia‐Pacific, and central and South America | 3.6 | 34 | Citations (PDF) |
| 205 | Increased mortality among Indigenous persons during and after release from prison in New South Wales | 1.7 | 20 | Citations (PDF) |
| 206 | Human papillomavirus and head and neck cancers: emerging trends and improving survival | 1.7 | 2 | Citations (PDF) |
| 207 | Survival after diagnosis of hepatocellular carcinoma and potential impact of treatment in a hepatitis B or C infected cohort | 3.1 | 6 | Citations (PDF) |
| 208 | High Rates of Late HIV Diagnosis Among People Who Inject Drugs Compared to Men Who Have Sex with Men and Heterosexual Men and Women in Australia | 2.0 | 9 | Citations (PDF) |
| 209 | Trends in mortality after diagnosis of hepatitis B or C infection: 1992–2006 | 3.6 | 46 | Citations (PDF) |
| 210 | Trends in anal cancer in Australia, 1982–2005 | 3.2 | 96 | Citations (PDF) |
| 211 | Counting the cost: estimating the number of deaths among recently released prisoners in Australia | 1.8 | 50 | Citations (PDF) |
| 212 | Predictors of deferral of treatment for hepatitis C infection in Australian clinics | 1.8 | 44 | Citations (PDF) |
| 213 | Predictors and Outcomes of HIV-Infected Antiretroviral-Naive Patients With Discordant Responses to Combination Antiretroviral Treatment in Asian and Australian Populations: Results From APHOD | 1.8 | 1 | Citations (PDF) |
| 214 | Economic evaluation of monitoring virologic responses to antiretroviral therapy in HIV-infected children in resource-limited settingsAids, 2011, 25, 1143-1151 | 2.5 | 18 | Citations (PDF) |
| 215 | The Coding Causes of Death in HIV (CoDe) Project | 2.9 | 143 | Citations (PDF) |
| 216 | Prevalence of and risk factors for lipodystrophy among HIV-infected patients receiving combined antiretroviral treatment in the Asia-Pacific region: results from the TREAT Asia HIV Observational Database (TAHOD) | 1.7 | 19 | Citations (PDF) |
| 217 | Risk factors for hepatocellular carcinoma in a cohort infected with hepatitis B or C | 2.7 | 47 | Citations (PDF) |
| 218 | Increasing cancer mortality among opioid‐dependent persons in Australia: a new public health challenge for a disadvantaged population | 1.7 | 56 | Citations (PDF) |
| 219 | Trends in detectable viral load by calendar year in the Australian HIV observational database | 3.6 | 30 | Citations (PDF) |
| 220 | Trends in all cause and viral liver disease-related hospitalizations in people with hepatitis B or C: a population-based linkage study | 3.3 | 15 | Citations (PDF) |
| 221 | Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection | 3.8 | 1,032 | Citations (PDF) |
| 222 | HIV-1 Drug Resistance Mutations Among Antiretroviral-Naive HIV-1-Infected Patients in Asia: Results From the TREAT Asia Studies to Evaluate Resistance-Monitoring Study | 5.4 | 45 | Citations (PDF) |
| 223 | CD4 Cell Responses to Combination Antiretroviral Therapy in Patients Starting Therapy at High CD4 Cell Counts | 1.8 | 11 | Citations (PDF) |
| 224 | Disproportionate Impact of Combination Antiretroviral Therapy on AIDS Incidence in Australia: Results from a Modified Back-projection Model | 2.0 | 1 | Citations (PDF) |
| 225 | Clinical Predictors of Immune Reconstitution following Combination Antiretroviral Therapy in Patients from the Australian HIV Observational Database | 2.4 | 39 | Citations (PDF) |
| 226 | Per-contact probability of HIV transmission in homosexual men in Sydney in the era of HAART | 2.5 | 232 | Citations (PDF) |
| 227 | Antiretroviral Therapy Outcomes of HIV-Infected Children in the TREAT Asia Pediatric HIV Observational Database | 1.8 | 40 | Citations (PDF) |
| 228 | Immunodeficiency and the risk of serious clinical endpoints in a well studied cohort of treated HIV-infected patientsAids, 2010, 24, 1877-1886 | 2.5 | 73 | Citations (PDF) |
| 229 | Hospitalizations in a cohort of HIV patients in Australia, 1999–2007Aids, 2010, 24, 1329-1339 | 2.5 | 22 | Citations (PDF) |
| 230 | Factors associated with specific causes of death amongst HIV-positive individuals in the D:A:D studyAids, 2010, 24, 1537-1548 | 2.5 | 396 | Citations (PDF) |
| 231 | HBV or HCV Coinfections and Risk of Myocardial Infarction in HIV-Infected Individuals: The D:A:D Cohort Study | 2.1 | 38 | Citations (PDF) |
| 232 | Trends in CD4 counts in HIV-infected patients with HIV viral load monitoring while on combination antiretroviral treatment: results from The TREAT Asia HIV Observational Database | 2.8 | 25 | Citations (PDF) |
| 233 | Reproducibility of adenosine stress cardiovascular magnetic resonance in multi-vessel symptomatic coronary artery disease | 4.5 | 32 | Citations (PDF) |
| 234 | Cancers in the TREAT Asia HIV Observational Database (TAHOD): a retrospective analysis of risk factors | 3.6 | 28 | Citations (PDF) |
| 235 | Hidden Drug Resistant HIV to Emerge in the Era of Universal Treatment Access in Southeast Asia | 2.4 | 21 | Citations (PDF) |
| 236 | Risk of Myocardial Infarction in Patients with HIV Infection Exposed to Specific Individual Antiretroviral Drugs from the 3 Major Drug Classes: The Data Collection on Adverse Events of Anti‐HIV Drugs (D:A:D) Study | 3.8 | 607 | Citations (PDF) |
| 237 | Predicting the risk of cardiovascular disease in HIV-infected patients: the Data collection on Adverse Effects of Anti-HIV Drugs Study | 2.4 | 333 | Citations (PDF) |
| 238 | Vaccine-induced IgG2 anti-HIV p24 is associated with control of HIV in patients with a ‘high-affinity’ FcγRIIa genotypeAids, 2010, 24, 1983-1990 | 2.5 | 37 | Citations (PDF) |
| 239 | Hospital-related morbidity in people notified with hepatitis C: A population-based record linkage study in New South Wales, Australia | 3.6 | 14 | Citations (PDF) |
| 240 | High Viral Fitness during Acute HIV-1 Infection | 2.4 | 12 | Citations (PDF) |
| 241 | Difference in Absolute CD4+ Count According to CD4 Percentage between Asian and Caucasian HIV-Infected Patients | 0.3 | 27 | Citations (PDF) |
| 242 | Enhanced geographically restricted surveillance simulates sporadic Creutzfeldt-Jakob disease clusterBrain, 2009, 132, 493-501 | 8.5 | 27 | Citations (PDF) |
| 243 | Long-Term Patterns in CD4 Response Are Determined by an Interaction Between Baseline CD4 Cell Count, Viral Load, and Time: The Asia Pacific HIV Observational Database (APHOD) | 1.8 | 44 | Citations (PDF) |
| 244 | Continuing declines in some but not all HIV-associated cancers in Australia after widespread use of antiretroviral therapyAids, 2009, 23, 2183-2190 | 2.5 | 117 | Citations (PDF) |
| 245 | The Impact of Needle and Syringe Programs on HIV and HCV Transmissions in Injecting Drug Users in Australia: A Model-Based Analysis | 1.8 | 68 | Citations (PDF) |
| 246 | The safety of candidate vaginal microbicides since nonoxynol-9: a systematic review of published studiesAids, 2009, 23, 1245-1254 | 2.5 | 21 | Citations (PDF) |
| 247 | Dietary Intake in HIV-Infected Men with Lipodystrophy: Relationships with Body Composition, Visceral Fat, Lipid, Glucose and Adipokine Metabolism | 0.8 | 9 | Citations (PDF) |
| 248 | Presence of the Metabolic Syndrome Is Not a Better Predictor of Cardiovascular Disease Than the Sum of Its Components in HIV-Infected Individuals: Data Collection on Adverse events of Anti-HIV Drugs (D:A:D) study | 6.5 | 34 | Citations (PDF) |
| 249 | Reply to DiNubile | 5.4 | 1 | Citations (PDF) |
| 250 | Evolution of CD4<sup>+</sup> T Cell Count in HIV-1-Infected Adults Receiving Antiretroviral Therapy with Sustained Long-Term Virological Suppression | 1.5 | 10 | Citations (PDF) |
| 251 | Short‐Term Clinical Disease Progression in HIV‐Infected Patients Receiving Combination Antiretroviral Therapy: Results from the TREAT Asia HIV Observational Database | 5.4 | 25 | Citations (PDF) |
| 252 | Diabetes Mellitus, Preexisting Coronary Heart Disease, and the Risk of Subsequent Coronary Heart Disease Events in Patients Infected With Human Immunodeficiency Virus | 25.2 | 93 | Citations (PDF) |
| 253 | TREAT Asia Quality Assessment Scheme (TAQAS) to standardize the outcome of HIV genotypic resistance testing in a group of Asian laboratories | 1.7 | 35 | Citations (PDF) |
| 254 | Recurrent urinary tract infections in women with symptoms of pelvic floor dysfunction | 1.6 | 34 | Citations (PDF) |
| 255 | Characterizing trends in HIV infection among men who have sex with men in Australia by birth cohorts: results from a modified back‐projection method | 3.6 | 27 | Citations (PDF) |
| 256 | Opioid agonist pharmacotherapy in New South Wales from 1985 to 2006: patient characteristics and patterns and predictors of treatment retention | 5.4 | 82 | Citations (PDF) |
| 257 | Estimating population attributable risk for hepatitis C seroconversion in injecting drug users in Australia: implications for prevention policy and planning | 5.4 | 28 | Citations (PDF) |
| 258 | Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cells | 39.5 | 268 | Citations (PDF) |
| 259 | Predictors and survival in hepatitis B‐related hepatocellular carcinoma in New South Wales, Australia | 2.7 | 12 | Citations (PDF) |
| 260 | The epidemiology of hepatitis C in Australia: Notifications, treatment uptake and liver transplantations, 1997–2006 | 2.7 | 59 | Citations (PDF) |
| 261 | Mortality among clients of a state-wide opioid pharmacotherapy program over 20 years: Risk factors and lives saved | 3.0 | 331 | Citations (PDF) |
| 262 | AIDS-related and non-AIDS-related mortality in the Asia-Pacific region in the era of combination antiretroviral treatmentAids, 2009, 23, 2323-2336 | 2.5 | 32 | Citations (PDF) |
| 263 | Patient Characteristics and Treatment Outcome Associated with Protease Inhibitor (PI) use in the Asia-Pacific Region | 2.9 | 2 | Citations (PDF) |
| 264 | An enormous hepatitis B virus‐related liver disease burden projected in Vietnam by 2025 | 4.1 | 70 | Citations (PDF) |
| 265 | Estimates and projections of hepatitis B‐related hepatocellular carcinoma in Australia among people born in Asia‐Pacific countries | 2.7 | 26 | Citations (PDF) |
| 266 | Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration | 52.8 | 844 | Citations (PDF) |
| 267 | Relation between HIV viral load and infectiousness: a model-based analysis | 52.8 | 340 | Citations (PDF) |
| 268 | Immediate Postvoid Residual Volumes in Women With Symptoms of Pelvic Floor Dysfunction | 1.4 | 54 | Citations (PDF) |
| 269 | HIV-induced immunodeficiency and mortality from AIDS-defining and non-AIDS-defining malignanciesAids, 2008, 22, 2143-2153 | 2.5 | 214 | Citations (PDF) |
| 270 | Major Clinical Outcomes in Antiretroviral Therapy (ART)–Naive Participants and in Those Not Receiving ART at Baseline in the SMART Study | 3.8 | 374 | Citations (PDF) |
| 271 | Control of Viremia and Prevention of AIDS following Immunotherapy of SIV-Infected Macaques with Peptide-Pulsed Blood | 4.4 | 47 | Citations (PDF) |
| 272 | Development of Appropriate Coronary Heart Disease Risk Prediction Models in HIV-Infected Patients | 25.2 | 31 | Citations (PDF) |
| 273 | Does the presenting bladder volume at urodynamics have any diagnostic relevance? | 1.6 | 6 | Citations (PDF) |
| 274 | Class of Antiretroviral Drugs and the Risk of Myocardial Infarction | 43.7 | 1,432 | Citations (PDF) |
| 275 | Increased Incidence of Squamous Cell Carcinoma of Eye After Kidney Transplantation | 4.7 | 35 | Citations (PDF) |
| 276 | The Safety, Efficacy, and Pharmacokinetic Profile of a Switch in Antiretroviral Therapy to Saquinavir, Ritonavir, and Atazanavir Alone for 48 Weeks and a Switch in the Saquinavir Formulation | 5.4 | 17 | Citations (PDF) |
| 277 | Metabolic syndrome, cardiovascular disease and type 2 diabetes mellitus after initiation of antiretroviral therapy in HIV infectionAids, 2007, 21, 2445-2453 | 2.5 | 169 | Citations (PDF) |
| 278 | Antiretroviral therapy with the integrase inhibitor raltegravir alters decay kinetics of HIV, significantly reducing the second phaseAids, 2007, 21, 2315-2321 | 2.5 | 173 | Citations (PDF) |
| 279 | Modelling the hepatitis C virus epidemic in Australia | 3.0 | 117 | Citations (PDF) |
| 280 | Suicide risk among recently released prisoners in New South Wales, Australia | 1.8 | 109 | Citations (PDF) |
| 281 | Impact of drug classes and treatment availability on the rate of antiretroviral treatment change in the TREAT Asia HIV Observational Database (TAHOD) | 2.3 | 26 | Citations (PDF) |
| 282 | A feasible method for linkage studies avoiding clerical review: linkage of the national HIV/AIDS surveillance databases with the National Death Index in Australia | 1.7 | 9 | Citations (PDF) |
| 283 | Liver cancer and hepatitis B and C in New South Wales, 1990–2002: a linkage study | 1.7 | 32 | Citations (PDF) |
| 284 | Factors associated with mortality in a cohort of Australian prisoners | 6.1 | 107 | Citations (PDF) |
| 285 | Effect of Transient Antiretroviral Treatment during acute HIV Infection: Comparison of the Quest Trial Results with CASCADE Natural History Study | 2.1 | 25 | Citations (PDF) |
| 286 | Causes of death after diagnosis of hepatitis B or hepatitis C infection: a large community-based linkage study | 52.8 | 243 | Citations (PDF) |
| 287 | Cancer Incidence Before and After Kidney Transplantation | 17.1 | 1,038 | Citations (PDF) |
| 288 | Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study | 3.6 | 148 | Citations (PDF) |
| 289 | Cancer Incidence among Australian Nuclear Industry Workers | 1.7 | 16 | Citations (PDF) |
| 290 | Cardiovascular complications of HIV: an overview of risk and a novel approach to prevention ??? the HIV polypill study | 3.3 | 4 | Citations (PDF) |
| 291 | Response from the authors | 1.7 | 0 | Citations (PDF) |
| 292 | The Role of Hydroxyurea in Enhancing the Virologic Control Achieved Through Structured Treatment Interruption in Primary HIV Infection | 1.8 | 26 | Citations (PDF) |
| 293 | Changes in Body Composition and Mitochondrial Nucleic Acid Content in Patients Switched from Failed Nucleoside Analogue Therapy to Ritonavir‐Boosted Indinavir and Efavirenz | 3.8 | 31 | Citations (PDF) |
| 294 | A Randomised Trial Comparing Genotypic and Virtual Phenotypic Interpretation of HIV Drug Resistance: The CREST Study | 3.0 | 26 | Citations (PDF) |
| 295 | Liver-Related Deaths in Persons Infected With the Human Immunodeficiency Virus | 8.6 | 1,020 | Citations (PDF) |
| 296 | Has the true prevalence of voiding difficulty in urogynecology patients been underestimated? | 1.6 | 53 | Citations (PDF) |
| 297 | Evaluation of the HIV Lipodystrophy Case Definition in a Placebo-Controlled, 144-Week Study in Antiretroviral-Naive Adults | 2.1 | 25 | Citations (PDF) |
| 298 | Buffalo Hump Seen in HIV-Associated Lipodystrophy is Associated With Hyperinsulinemia But Not Dyslipidemia | 1.8 | 52 | Citations (PDF) |
| 299 | The TREAT Asia HIV Observational Database | 1.8 | 154 | Citations (PDF) |
| 300 | HIV disease progression in a patient cohort treated via a clinical research network in a resource limited setting | 2.5 | 29 | Citations (PDF) |
| 301 | Mortality among prisoners: how accurate is the Australian National Death Index? | 1.7 | 35 | Citations (PDF) |
| 302 | Mortality rates among nuclear industry workers at Lucas Heights Science and Technology Centre | 1.7 | 18 | Citations (PDF) |
| 303 | Mucosally-administered human–simian immunodeficiency virus DNA and fowlpoxvirus-based recombinant vaccines reduce acute phase viral replication in macaques following vaginal challenge with CCR5-tropic SHIVSF162P3 | 3.2 | 60 | Citations (PDF) |
| 304 | Predictors of Hypertension and Changes of Blood Pressure in HIV-Infected Patients | 2.1 | 106 | Citations (PDF) |
| 305 | Progression of Lipodystrophy (LD) with Continued Thymidine Analogue Usage: Long-Term Follow-Up from a Randomized Clinical Trial (The PIILR Study) | 2.2 | 14 | Citations (PDF) |
| 306 | Modeling Trends in HIV Incidence Among Homosexual Men in Australia 1995???2006 | 1.8 | 27 | Citations (PDF) |
| 307 | Estimates of chronic hepatitis B virus infection in Australia, 2000 | 1.7 | 96 | Citations (PDF) |
| 308 | Evaluation in macaques of HIV-1 DNA vaccines containing primate CpG motifs and fowlpoxvirus vaccines co-expressing IFN? or IL-12 | 3.2 | 47 | Citations (PDF) |
| 309 | No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial | 52.8 | 242 | Citations (PDF) |
| 310 | Predictors of trend in CD4-positive T-cell count and mortality among HIV-1-infected individuals with virological failure to all three antiretroviral-drug classes | 52.8 | 307 | Citations (PDF) |
| 311 | Effectiveness of needle and syringe programmes for preventing HIV transmission | 3.4 | 89 | Citations (PDF) |
| 312 | Estimating the effect of antiretroviral treatment during HIV seroconversion: impact of confounding in observational data | 2.9 | 9 | Citations (PDF) |
| 313 | Selective exclusion of treatment arms in multi-arm randomized clinical trials | 1.7 | 7 | Citations (PDF) |
| 314 | The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection | 3.6 | 64 | Citations (PDF) |
| 315 | Epidemiology of hepatitis C virus infection in Australia | 3.1 | 167 | Citations (PDF) |
| 316 | Modelling hepatitis C virus incidence, prevalence and long-term sequelae in Australia, 2001 | 5.1 | 131 | Citations (PDF) |
| 317 | The impact of behavioural changes on the prevalence of human immunodeficiency virus and hepatitis C among injecting drug users | 5.1 | 53 | Citations (PDF) |
| 318 | Cardiovascular disease risk factors in HIV patients – association with antiretroviral therapy. Results from the DAD studyAids, 2003, 17, 1179-1193 | 2.5 | 797 | Citations (PDF) |
| 319 | Combination Antiretroviral Therapy and the Risk of Myocardial Infarction | 43.7 | 1,590 | Citations (PDF) |
| 320 | Centralized Assessment of Dual-Energy X-ray Absorptiometry (DEXA) in Multicenter Studies of HIV-Associated Lipodystrophy | 2.2 | 13 | Citations (PDF) |
| 321 | Limited Evolution of HIV Antiretroviral Drug Resistance-Associated Mutations During the Performance of Drug Resistance Testing | 1.8 | 12 | Citations (PDF) |
| 322 | An Objective Lipodystrophy Severity Grading Scale Derived From the Lipodystrophy Case Definition Score | 1.8 | 84 | Citations (PDF) |
| 323 | Lactate concentrations distinguish between nucleoside neuropathy and HIV neuropathyAids, 2003, 17, 1094-1096 | 2.5 | 49 | Citations (PDF) |
| 324 | Natural History Models for Hepatitis C-Related Liver Disease: Different Disease Progression Parameters for Different Settings | 2.1 | 19 | Citations (PDF) |
| 325 | HIV Lipodystrophy Case Definition using Artificial Neural Network Modelling | 2.1 | 11 | Citations (PDF) |
| 326 | Dynamics of T Cells and TCR Excision Circles Differ After Treatment of Acute and Chronic HIV Infection | 0.6 | 49 | Citations (PDF) |
| 327 | Abacavir Substitution for Nucleoside Analogs in Patients With HIV Lipoatrophy<SUBTITLE>A Randomized Trial</SUBTITLE> | 17.1 | 271 | Citations (PDF) |
| 328 | A randomized, double-blind study of gemfibrozil for the treatment of protease inhibitor-associated hypertriglyceridaemiaAids, 2002, 16, 2195-2200 | 2.5 | 83 | Citations (PDF) |
| 329 | Randomized, open-Label, comparative trial to evaluate the efficacy and safety of three antiretroviral drug combinations including two nucleoside analogues and nevirapine for previously untreated HIV-1 Infection: The OzCombo 2 study | 2.2 | 45 | Citations (PDF) |
| 330 | Estimation of Risk of Cancers before Occurrence of Acquired Immunodeficiency Syndrome in Persons Infected with Human Immunodeficiency Virus | 3.4 | 23 | Citations (PDF) |
| 331 | Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosisAids, 2002, 16, 1155-1161 | 2.5 | 210 | Citations (PDF) |
| 332 | Is severe liver disease a common outcome for people with chronic hepatitisC? | 2.7 | 82 | Citations (PDF) |
| 333 | Thymidine analogue withdrawal for lipoatrophic patients on protease-sparing therapy improves lipoatrophy but compromises antiviral controlAids, 2002, 16, 2489-2491 | 2.5 | 18 | Citations (PDF) |
| 334 | Analysis of Virological Efficacy in Trials of Antiretroviral Regimens: Drawbacks of Not Including Viral Load Measurements after Premature Discontinuation of Therapy | 2.1 | 15 | Citations (PDF) |
| 335 | The cost of hepatitis C and the cost–effectiveness of its prevention | 2.9 | 16 | Citations (PDF) |
| 336 | Modelling the effect of combination antiretroviral treatments on HIV incidenceAids, 2001, 15, 1287-1294 | 2.5 | 114 | Citations (PDF) |
| 337 | A Randomized Trial of Nelfinavir, Ritonavir, or Delavirdine in Combination with Saquinavir-SGC and Stavudine in Treatment-Experienced HIV-1-Infected Patients | 2.2 | 9 | Citations (PDF) |
| 338 | Back-projection estimates of the number of dependent heroin users in Australia | 5.4 | 46 | Citations (PDF) |
| 339 | Estimating progression to cirrhosis in chronic hepatitis C virus infection | 10.6 | 544 | Citations (PDF) |
| 340 | Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy | 2.5 | 143 | Citations (PDF) |
| 341 | Baseline Antiretroviral Drug Susceptibility Influences Treatment Response in Patients Receiving Saquinavir-Enhancing Therapy | 2.2 | 8 | Citations (PDF) |
| 342 | HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre studyAids, 2001, 15, 1811-1822 | 2.5 | 156 | Citations (PDF) |
| 343 | A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome | 2.5 | 547 | Citations (PDF) |
| 344 | A randomised, open-label comparison of three highly active antiretroviral therapy regimens including two nucleoside analogues and indinavir for previously untreated HIV-1 infection: the OzCombo1 studyAids, 2000, 14, 1171-1180 | 2.5 | 76 | Citations (PDF) |
| 345 | Problems with Publishing Results of Interim Analyses of Randomized Clinical Trials | 2.2 | 4 | Citations (PDF) |
| 346 | B-cell stimulation and prolonged immune deficiency are risk factors for non-Hodgkin's lymphoma in people with AIDS | 2.5 | 127 | Citations (PDF) |
| 347 | Estimating the population impact in Australia of improved antiretroviral treatment for HIV infection | 2.5 | 59 | Citations (PDF) |
| 348 | Primary hepatocellular carcinoma in Australia, 1978‐1997: increasing incidence and mortality | 1.8 | 73 | Citations (PDF) |
| 349 | How many dependent heroin users are there in Australia? | 1.8 | 138 | Citations (PDF) |
| 350 | A Randomized, Controlled, Phase II Trial Comparing Escalating Doses of Subcutaneous Interleukin‐2 plus Antiretrovirals versus Antiretrovirals Alone in Human Immunodeficiency Virus–Infected Patients with CD4+Cell Counts ⩾350/mm3 | 3.8 | 69 | Citations (PDF) |
| 351 | Lipodystrophy following antiretroviral therapy of primary HIV infectionAids, 2000, 14, 2406-2407 | 2.5 | 47 | Citations (PDF) |
| 352 | Therapeutic Vaccination with p24-VLP and Zidovudine Augments HIV-Specific Cytotoxic T Lymphocyte Activity in Asymptomatic HIV-Infected Individuals | 1.5 | 32 | Citations (PDF) |
| 353 | Vinblastine Pharmacokinetics in Patients with Non-Small Cell Lung Cancer Given Cisplatin | 1.7 | 5 | Citations (PDF) |
| 354 | AIDS diagnoses at higher CD4 counts in Australia following the introduction of highly active antiretroviral treatment | 2.5 | 23 | Citations (PDF) |
| 355 | Risk of cancer in people with AIDS | 2.5 | 177 | Citations (PDF) |
| 356 | Impact of Early HIV-1 RNA and T-Lymphocyte Dynamics During Primary HIV-1 Infection on the Subsequent Course of HIV-1 RNA Levels and CD4+ T-Lymphocyte Counts in the First Year of HIV-1 Infection | 1.8 | 27 | Citations (PDF) |
| 357 | Impact of Early HIV-1 RNA and T-Lymphocyte Dynamics During Primary HIV-1 Infection on the Subsequent Course of HIV-1 RNA Levels and CD4+ T-Lymphocyte Counts in the First Year of HIV-1 Infection | 1.8 | 19 | Citations (PDF) |
| 358 | Rising incidence of oesophageal adenocarcinoma in men in Australia | 2.7 | 95 | Citations (PDF) |
| 359 | A comparison of adjuvant psychological therapy and supportive counselling in patients with cancer 1998, 7, 218-228 | | 100 | Citations (PDF) |
| 360 | Patterns of Viral Dynamics during Primary Human Immunodeficiency Virus Type 1 Infection | 3.8 | 86 | Citations (PDF) |
| 361 | Predictors of Progression in Long-Term Nonprogressors | 1.5 | 29 | Citations (PDF) |
| 362 | Time trends in HIV infection among pregnant women in Europe | 2.5 | 11 | Citations (PDF) |
| 363 | A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors | 2.5 | 2,174 | Citations (PDF) |
| 364 | HIV disease progression in Australia in the time of combination antiretroviral therapies | 1.8 | 50 | Citations (PDF) |
| 365 | Levels of Human Immunodeficiency Virus Type 1 RNA in Cerebrospinal Fluid Correlate with AIDS Dementia Stage | 3.8 | 263 | Citations (PDF) |
| 366 | Prospective Analysis of Seizures Occurring in Human Immunodeficiency Virus Type-1 Infection | 0.0 | 33 | Citations (PDF) |
| 367 | Acute toxicity in pelvic radiotherapy; a randomised trial of conformal versus conventional treatment | 2.0 | 88 | Citations (PDF) |
| 368 | Spinal cord compression in prostate cancer: treatment outcome and prognostic factors | 2.0 | 72 | Citations (PDF) |
| 369 | Incidence of HIV infection in a cohort of homosexually active men | 1.7 | 6 | Citations (PDF) |
| 370 | Author's Reply: Survival analysis of randomized clinical trials adjusted for patients who switch treatments by M. G. Law and J. M. Kaldor,Statistics in Medicine,15, 2069-2076 (1996) | 1.7 | 1 | Citations (PDF) |
| 371 | Accuracy of pelvic radiotherapy: prospective analysis of 90 patients in a randomised trial of blocked versus standard radiotherapy | 2.0 | 44 | Citations (PDF) |
| 372 | Age‐specific HIV incidence among homosexually active men in Australia | 1.8 | 10 | Citations (PDF) |
| 373 | Sample size calculations for within-patient comparisons with a binary or survival endpoint | 2.8 | 0 | Citations (PDF) |
| 374 | SURVIVAL ANALYSES OF RANDOMIZED CLINICAL TRIALS ADJUSTED FOR PATIENTS WHO SWITCH TREATMENTS 1996, 15, 2069-2076 | | 20 | Citations (PDF) |
| 375 | Estimation of cumulative HIV incidence in Australia, based on national case reporting | 1.7 | 7 | Citations (PDF) |
| 376 | Primary Infection with Zidovudine-Resistant Human Immunodeficiency Virus Type 1 Does Not Adversely Affect Outcome at 1 Year | 3.8 | 37 | Citations (PDF) |
| 377 | CD8+ Lymphocyte Responses to Antiretroviral Therapy of HIV Infection | 0.3 | 49 | Citations (PDF) |
| 378 | The role of initial AIDS-defining illness in survival following AIDS | 2.5 | 49 | Citations (PDF) |
| 379 | Expression of 2 variant forms of fibroblast growth factor receptor 1 in human breast | 4.5 | 42 | Citations (PDF) |
| 380 | The Mini-MAC | 2.1 | 341 | Citations (PDF) |
| 381 | Adjuvant psychological therapy for patients with cancer: Outcome at one year | 3.1 | 106 | Citations (PDF) |
| 382 | Planned and unplanned gaps in radiotherapy: the importance of gap position and gap duration | 2.0 | 87 | Citations (PDF) |
| 383 | Prognostic significance of aromatase and estrone sulfatase enzymes in human breast cancer | 2.4 | 33 | Citations (PDF) |
